Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in early dementia associated with Parkinson's disease
ISRCTN30151023Phase 3Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Nov 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease dementia (PDD) comparing Donepezil with Placebo (2 arms). Primary endpoints: Mattis Dementia Rating Scale, Neuropsychiatric Inventory and 1 more. Started Nov 2009; status: completed.
02
Drugs
donepezil
03
Conditions
Parkinson's disease dementia (PDD)
Beyond the preview
Go deeper on ISRCTN30151023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN30151023.